Bridging naïve and primed pluripotency.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Transcription factor ZNF263 primes human embryonic stem cells for pluripotency dissolution and lineage commitment.Nature communications · 2025
   Article
2. Capture primed pluripotency in guinea pig.Stem cell reports · 2025
   Article
3. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells.Nucleic acids research · 2023
   Article
4. Opening the "Black Box" Underlying Barriers to the Use of Canine Induced Pluripotent Stem Cells: A Narrative Review.Stem cells and development · 2023
   Review
5. Capturing Transitional Pluripotency through Proline Metabolism.Cells · 2022
   Review
6. Transcriptomic Analysis of Human Naïve and Primed Pluripotent Stem Cells.Methods in molecular biology (Clifton, N.J.) · 2022
   Article
7. Cellular reprogramming and epigenetic rejuvenation.Clinical epigenetics · 2021
   Review

Corrections and comments

• Comment on
  In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states.2020

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as